Tumor localized agonistic anti-CD40 therapy and beyond
Volume: 20, Issue: 3, Pages: 215 - 217
Published: Jan 10, 2020
Abstract
The field of anti-CD40 agonistic antibody therapies is still awaiting the breakthrough in the clinic. Anti-CD40 agonistic antibodies should in theory complement anti-PD1/PDL1 therapy as they...
Paper Details
Title
Tumor localized agonistic anti-CD40 therapy and beyond
Published Date
Jan 10, 2020
Volume
20
Issue
3
Pages
215 - 217
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History